HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antineutrophil antibody: a test for autoimmune primary sclerosing cholangitis in childhood?

Abstract
The detection of an antineutrophil antibody which is highly sensitive and specific for adult primary sclerosing cholangitis using indirect immunoalkaline phosphatase has been previously described. In this study, the diagnostic potential of this method in childhood primary sclerosing cholangitis is described. A range of 72 blinded children's sera (36 boys), aged six months to 21 years (10 primary sclerosing cholangitis, eight autoimmune chronic active hepatitis, 10 alpha-1 antitrypsin deficiency, 12 extrahepatic bile duct atresia, 11 ulcerative colitis and 21 normal subjects) was assayed. Eight of the 10 primary sclerosing cholangitis patients were correctly identified. Three patients with chronic active hepatitis also showed the characteristic primary sclerosing cholangitis pattern of staining. No ulcerative colitis patients or any other patients showed this pattern of staining. All normal subjects were negative. As in adult primary sclerosing cholangitis, there is a specific antineutrophil antibody in childhood primary sclerosing cholangitis and this provides further evidence towards an autoimmune aetiology of this condition. The test may have diagnostic potential.
AuthorsS K Lo, R W Chapman, P Cheeseman, C P Charlton, J A Walker-Smith, G Mieli-Vergani, K A Fleming
JournalGut (Gut) Vol. 34 Issue 2 Pg. 199-202 (Feb 1993) ISSN: 0017-5749 [Print] England
PMID8432473 (Publication Type: Journal Article)
Chemical References
  • Autoantibodies
Topics
  • Adolescent
  • Adult
  • Autoantibodies (analysis)
  • Autoimmune Diseases (diagnosis, immunology)
  • Child
  • Child, Preschool
  • Cholangitis, Sclerosing (diagnosis, immunology)
  • Female
  • Hepatitis, Chronic (immunology)
  • Humans
  • Immunoenzyme Techniques
  • Infant
  • Male
  • Neutrophils (immunology)
  • Single-Blind Method

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: